Skip to content

A randomized controlled trial comparing non-transecting Anastomotic Repair and transecting anastomotic repair in isolated short bulbar urethral strictures

A randomized controlled trial comparing non-transecting Anastomotic Repair and transecting anastomotic repair in isolated short bulbar urethral strictures

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035426
Enrollment
Unknown
Registered
2020-08-10
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Stricture

Interventions

nTAR group:non-transecting Anastomotic Repair
TAR group:transecting Anastomotic Repair

Sponsors

Shanghai Sixth people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Sign informed consent voluntarily and meet the requirements of GCP and relevant regulations 2. Aged >=18 years male; 3. Can tolerate surgery; 4. Single short segment (<=3 cm) bulbar urethral stricture was confirmed by imaging examination. Imaging examination included retrograde urethrography (rug). In order to improve the accuracy of the examination, we should also carry out voiding cystourethrography (VCUG) and urethroscopy; 5. The patients were able to follow up according to the follow-up plan.

Exclusion criteria

Exclusion criteria: 1. The patient is not suitable for surgical treatment; 2. Other parts of urethra (penile urethra, membranous urethra, prostatic urethra and bladder neck) were associated with stricture; 3. Urethral stricture was more than 3 cm; 4. The single stricture was located in other parts of urethra (penile urethra, membranous urethra, prostatic urethra and bladder neck); 5. Lichen sclerosus (LS) associated stenosis; 6. Urethral stricture caused by failure of hypospadias repair; 7. Neurogenic bladder; 8. The operation was changed to extended urethroplasty; 9. History of pelvic radiotherapy; 10. During the screening period, patients were actively treated with erectile function enhancement therapy (such as PDE5 inhibitor, intracavernous injection of penis, etc.); 11. Any situation that may interfere with the results of the study or significantly affect patient participation in the study; 12. The patient was unable to complete the follow-up as planned.

Design outcomes

Primary

MeasureTime frame
Urethrography;Urethroscopy;

Secondary

MeasureTime frame
IIEF-5;MSHQ-EjD questionnaire;ICIQ-MLUTS;Qmax;

Countries

China

Contacts

Public ContactQiang Fu

Shanghai Sixth people's Hospital

jamesqfu@aliyun.com+86 13501834727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026